West Pharmaceutical Services, Inc. Stock
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
10:41:04 2026-08-27 am EDT
|
5-day change | 1st Jan Change | ||
| 350.66 USD | +0.21% |
|
-1.27% | +26.95% |
| Aug. 26 | Boston Scientific hit by cyberattack, global operations affected | RE |
| Aug. 03 | Is everything under control? |  |
| Market Cap | 24.63B 21.14B 19.84B 18.12B 34.2B 2,349B 34.36B 235B 90.99B 1,185B 92.46B 90.46B 3,925B | P/E 2026 * |
40.8x | P/E 2027 * | 35.5x |
|---|---|---|---|---|---|
| Enterprise Value | 24.12B 20.7B 19.43B 17.75B 33.5B 2,301B 33.66B 230B 89.13B 1,161B 90.57B 88.61B 3,844B | EV / Sales 2026 * |
7.15x | EV / Sales 2027 * | 6.58x |
| Free-Float |
92.89% | Yield 2026 * |
0.26% | Yield 2027 * | 0.28% |
Last Transcript : West Pharmaceutical Services, Inc.
| Aug. 26 | West to Participate in Upcoming Investor Conferences | PR |
| Jul. 23 | West Pharmaceutical: Q2 Earnings Snapshot | AQ |
| Jul. 23 | West Reports Second-Quarter 2026 Results | PR |
| Jul. 21 | West Declares Quarterly Dividend | PR |
| Jul. 07 | West to Host Second-Quarter 2026 Conference Call | PR |
| 1 day | +0.19% | ||
| 1 week | -0.72% | ||
| Current month | +3.02% | ||
| 1 month | +6.03% | ||
| 3 months | +12.32% | ||
| 6 months | +38.10% | ||
| Current year | +27.66% |
| 1 week | 346.25 |  | 359.18 |
| 1 month | 330.41 | | 360.28 |
| Current year | 223.83 | | 386 |
| 1 year | 223.83 | | 386 |
| 3 years | 187.43 | | 415.73 |
| 5 years | 187.43 | | 475.35 |
| 10 years | 70.17 | | 475.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Green
CEO | Chief Executive Officer | 56 | 2015-04-23 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 2025-08-03 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 2025-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 2011-01-31 |
Douglas Michels
BRD | Director/Board Member | 69 | 2011-03-06 |
William Feehery
BRD | Director/Board Member | 56 | 2012-02-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/11/26 | Fiscal year | Chief Financial Officer | 17,408 | 0.0247% | ||
| 6/30/26 | Other | Director | 46 | 0.0001% | ||
| 5/4/26 | Free | Director | 791 | 0.0011% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.16% | -0.72% | +42.80% | -12.92% | 24.63B | |
| -1.39% | -1.37% | -14.36% | +9.52% | 197B | |
| -1.18% | -1.85% | -1.58% | +11.31% | 118B | |
| -1.51% | +2.95% | +11.50% | +79.60% | 62.55B | |
| -2.00% | -3.74% | +27.02% | +53.48% | 52.4B | |
| -0.60% | +0.42% | -3.58% | -33.08% | 51.81B | |
| +0.87% | -2.37% | +15.32% | -11.29% | 33.57B | |
| +0.32% | +6.11% | - | - | 30.34B | |
| -0.47% | +3.56% | -3.25% | +19.21% | 23.81B | |
| -1.10% | -0.92% | -6.19% | +2.52% | 23.09B | |
| Average | -0.67% | +0.78% | +7.52% | +13.15% | 61.74B | |
| Weighted average by Cap. | -1.02% | +0.07% | +0.47% | +15.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.37B 2.9B 2.72B 2.48B 4.69B 322B 4.71B 32.17B 12.47B 162B 12.67B 12.4B 538B | 3.59B 3.08B 2.89B 2.64B 4.98B 342B 5.01B 34.2B 13.25B 173B 13.47B 13.18B 572B |
| Net income | 615M 527M 495M 452M 853M 58.61B 857M 5.86B 2.27B 29.57B 2.31B 2.26B 97.94B | 701M 602M 565M 516M 974M 66.88B 978M 6.69B 2.59B 33.74B 2.63B 2.58B 112B |
| Net Debt | -503M -432M -405M -370M -699M -48B -702M -4.8B -1.86B -24.22B -1.89B -1.85B -80.21B | -1.04B -892M -837M -765M -1.44B -99.11B -1.45B -9.91B -3.84B -50B -3.9B -3.82B -166B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | $350.22 | +0.08% | 40,576 |
| 26-08-26 | $349.92 | +0.41% | 440,221 |
| 26-08-25 | $348.48 | -1.37% | 383,760 |
| 26-08-24 | $353.32 | +0.07% | 473,305 |
| 26-08-21 | $353.08 | -0.20% | 511,127 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
Select your edition
All financial news and data tailored to specific country editions
